Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
IndexNDX, S&P 500 P/E23.96 EPS (ttm)35.06 Insider Own4.30% Shs Outstand107.80M Perf Week3.10%
Market Cap91.53B Forward P/E19.19 EPS next Y43.78 Insider Trans-1.04% Shs Float104.26M Perf Month2.11%
Income3.99B PEG10.89 EPS next Q10.89 Inst Own85.20% Short Float / Ratio1.34% / 3.08 Perf Quarter0.79%
Sales13.10B P/S6.99 EPS this Y-4.89% Inst Trans-0.34% Short Interest1.40M Perf Half Y12.54%
Book/sh228.90 P/B3.67 EPS next Y2.33% ROA13.34% Target Price921.33 Perf Year9.93%
Cash/sh90.99 P/C9.23 EPS next 5Y2.20% ROE17.22% 52W Range668.00 - 853.97 Perf YTD16.45%
Dividend- P/FCF19.88 EPS past 5Y29.89% ROI14.46% 52W High-1.62% Beta0.15
Dividend %- Quick Ratio4.47 Sales past 5Y21.29% Gross Margin82.84% 52W Low25.77% ATR15.86
Employees11851 Current Ratio5.18 Sales Q/Q14.53% Oper. Margin33.69% RSI (14)63.09 Volatility2.28% 1.90%
OptionableYes Debt/Eq0.11 EPS Q/Q-23.81% Profit Margin30.47% Rel Volume0.82 Prev Close849.18
ShortableYes LT Debt/Eq0.11 EarningsNov 02 BMO Payout0.00% Avg Volume454.81K Price840.14
Recom1.82 SMA204.01% SMA503.31% SMA2006.87% Volume374,330 Change-1.06%
Date Action Analyst Rating Change Price Target Change
Nov-09-23Initiated Deutsche Bank Hold $800
Nov-03-23Upgrade Raymond James Mkt Perform → Outperform $950
Aug-21-23Upgrade Canaccord Genuity Hold → Buy $720 → $992
Aug-21-23Reiterated Oppenheimer Perform $950 → $1050
Jun-28-23Downgrade Canaccord Genuity Buy → Hold $953 → $720
Mar-27-23Upgrade SVB Securities Market Perform → Outperform $834 → $976
Mar-24-23Upgrade Jefferies Hold → Buy $675 → $925
Mar-23-23Upgrade Raymond James Underperform → Mkt Perform
Jan-30-23Upgrade Cowen Market Perform → Outperform $775 → $875
Jan-20-23Upgrade JP Morgan Neutral → Overweight $850
Today 12:07PM
Dec-07-23 07:44PM
02:30AM Loading…
Dec-06-23 03:45PM
Dec-04-23 06:19AM
Dec-02-23 02:05PM
Nov-30-23 04:05PM
Nov-27-23 04:27PM
Nov-24-23 11:29AM
04:05PM Loading…
Nov-15-23 04:05PM
Nov-13-23 09:00AM
Nov-09-23 10:01PM
Nov-07-23 11:15PM
Nov-06-23 04:01PM
Nov-03-23 11:47AM
Nov-02-23 04:06PM
12:31PM Loading…
Nov-01-23 04:00PM
Oct-31-23 10:01AM
Oct-27-23 08:37AM
Oct-26-23 04:00PM
Oct-25-23 04:05PM
Oct-23-23 09:40AM
Oct-22-23 02:59PM
Oct-21-23 08:48AM
Oct-20-23 05:00PM
Oct-18-23 09:30AM
Oct-16-23 09:26AM
Oct-15-23 06:05PM
Oct-14-23 10:44AM
Oct-13-23 02:35PM
Oct-10-23 02:00PM
Oct-09-23 02:03AM
Oct-07-23 03:33PM
Oct-06-23 12:10PM
Oct-05-23 12:32PM
Oct-04-23 09:27AM
Oct-03-23 07:58AM
Sep-30-23 05:30AM
Sep-29-23 08:30AM
Sep-28-23 04:05PM
Sep-27-23 02:47PM
Sep-26-23 08:11AM
Sep-25-23 05:13PM
Sep-22-23 02:57PM
Sep-20-23 10:07AM
Sep-15-23 09:32AM
Sep-09-23 06:55AM
Sep-08-23 05:39PM
Sep-07-23 11:30AM
Sep-06-23 11:14AM
Aug-31-23 01:43PM
Aug-25-23 10:15AM
Aug-24-23 10:15AM
Aug-23-23 04:05PM
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MURPHY ANDREW JEVP ResearchDec 05Sale817.446,5365,342,78759,421Dec 06 04:02 PM
MURPHY ANDREW JEVP ResearchDec 04Option Exercise270.4320,0005,408,60079,421Dec 06 04:02 PM
RYAN ARTHUR FDirectorDec 01Sale817.3010081,73018,447Dec 04 04:02 PM
MURPHY ANDREW JEVP ResearchNov 14Sale799.176,4925,188,21359,421Nov 15 04:02 PM
MURPHY ANDREW JEVP ResearchNov 13Option Exercise270.4320,0005,408,60079,421Nov 15 04:02 PM
RYAN ARTHUR FDirectorNov 07Sale827.9010082,79018,547Nov 08 04:07 PM
McCourt MarionEVP CommercialNov 01Option Exercise381.401,000381,40020,803Nov 02 04:03 PM
McCourt MarionEVP CommercialNov 01Sale783.911,000783,91019,803Nov 02 04:03 PM
Zoghbi Huda YDirectorOct 13Option Exercise391.921,000391,9202,247Oct 17 04:06 PM
Zoghbi Huda YDirectorOct 13Sale850.001,000850,0001,247Oct 17 04:06 PM
McCourt MarionEVP CommercialOct 02Option Exercise372.461,038386,61320,841Oct 03 04:04 PM
McCourt MarionEVP CommercialOct 02Sale827.001,038858,42619,803Oct 03 04:04 PM
McCourt MarionEVP CommercialSep 01Sale834.55250208,63819,803Sep 06 04:03 PM
Van Plew Daniel PEVP & General Mgr, IndustrialAug 24Sale841.716,1975,216,07321,508Aug 25 04:02 PM
Van Plew Daniel PEVP & General Mgr, IndustrialAug 23Option Exercise381.4023,1258,819,87544,633Aug 25 04:02 PM
POON CHRISTINE ADirectorAug 23Option Exercise273.6712,2803,360,66814,317Aug 25 04:02 PM
Fenimore Christopher R.SVP ControllerAug 23Option Exercise399.667,0002,797,62026,140Aug 25 04:03 PM
POON CHRISTINE ADirectorAug 23Sale839.9712,28010,314,8292,037Aug 25 04:02 PM
Landry Robert EEVP Finance CFOAug 23Sale844.00223188,21231,699Aug 25 04:02 PM
STAHL NEILEVP Research and DevelopmentAug 22Sale840.9811,6659,810,08253,100Aug 23 04:03 PM
STAHL NEILEVP Research and DevelopmentAug 21Option Exercise399.6650,00019,983,000103,100Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 21Option Exercise391.92853334,3082,100Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 21Sale829.00853707,1371,247Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 10Option Exercise391.92853334,3082,100Aug 11 04:13 PM
Bassler Bonnie LDirectorAug 10Sale789.00853673,0171,247Aug 11 04:13 PM
McCourt MarionEVP CommercialAug 01Sale744.66250186,16520,053Aug 03 04:02 PM
RYAN ARTHUR FDirectorAug 01Sale736.5910073,65918,647Aug 03 04:25 PM
McCourt MarionEVP CommercialJul 03Sale710.09250177,52220,303Jul 06 04:02 PM
RYAN ARTHUR FDirectorJul 03Sale716.8810071,68818,747Jul 06 04:01 PM
McCourt MarionEVP CommercialJun 01Sale736.00250184,00020,553Jun 02 04:12 PM
RYAN ARTHUR FDirectorJun 01Sale735.4210073,54218,847Jun 02 04:14 PM
RYAN ARTHUR FDirectorMay 01Sale805.3310080,53318,947May 03 04:01 PM
BROWN MICHAEL SDirectorApr 21Option Exercise520.013,0701,596,4314,317Apr 24 04:05 PM
BROWN MICHAEL SDirectorApr 21Sale798.423,0702,451,1491,247Apr 24 04:05 PM
McCourt MarionEVP CommercialApr 03Option Exercise372.461,100409,70621,903Apr 05 04:00 PM
McCourt MarionEVP CommercialApr 03Sale818.801,100900,68020,803Apr 05 04:00 PM
RYAN ARTHUR FDirectorApr 03Sale819.3110081,93119,047Apr 05 04:01 PM
Landry Robert EEVP Finance CFOMar 28Sale823.471,007829,23331,922Mar 29 04:07 PM
Landry Robert EEVP Finance CFOMar 27Option Exercise379.603,8001,442,47635,316Mar 29 04:07 PM
Landry Robert EEVP Finance CFOMar 27Sale821.70183150,37232,929Mar 29 04:07 PM
Bassler Bonnie LDirectorMar 24Option Exercise380.951,240472,3782,487Mar 27 04:43 PM
Bassler Bonnie LDirectorMar 24Sale818.001,2401,014,3201,247Mar 27 04:43 PM
LAROSA JOSEPH JEVP General Counsel and SecretMar 23Option Exercise270.4310,0002,704,30034,213Mar 27 04:39 PM
YANCOPOULOS GEORGEPresident and Chief ScientificMar 23Sale804.263,6562,940,374196,848Mar 27 04:41 PM
Fenimore Christopher R.SVP ControllerMar 23Sale806.472,1921,767,78218,409Mar 27 04:37 PM
McCourt MarionEVP CommercialMar 01Option Exercise372.461,100409,70621,903Mar 03 04:03 PM
McCourt MarionEVP CommercialMar 01Sale759.891,100835,87920,803Mar 03 04:03 PM
RYAN ARTHUR FDirectorMar 01Sale762.5010076,25019,147Mar 03 04:03 PM
VAGELOS P ROYDirectorFeb 22Option Exercise270.4342,50011,493,275366,583Feb 24 04:07 PM
McCourt MarionEVP CommercialFeb 07Option Exercise372.461,000372,46023,079Feb 08 04:14 PM
McCourt MarionEVP CommercialFeb 07Sale769.041,000769,04022,079Feb 08 04:14 PM
GOLDSTEIN JOSEPH LDirectorFeb 06Option Exercise482.683,6131,743,9239,860Feb 08 04:16 PM
BROWN MICHAEL SDirectorFeb 06Option Exercise520.013,0711,596,9514,318Feb 08 04:15 PM
YANCOPOULOS GEORGEPresident and Chief ScientificFeb 06Sale800.0813,18910,552,255200,504Feb 08 04:15 PM
GOLDSTEIN JOSEPH LDirectorFeb 06Sale800.003,6132,890,4006,247Feb 08 04:16 PM
BROWN MICHAEL SDirectorFeb 06Sale798.003,0712,450,6581,247Feb 08 04:15 PM
Landry Robert EEVP Finance CFOFeb 06Sale788.88752593,23832,105Feb 07 04:09 PM
BROWN MICHAEL SDirectorFeb 06Sale797.00500398,5006,162Feb 08 04:15 PM
Fenimore Christopher R.SVP ControllerFeb 03Option Exercise270.435,0001,352,15023,581Feb 07 04:10 PM
Landry Robert EEVP Finance CFOFeb 03Option Exercise381.923,0001,145,76035,105Feb 07 04:09 PM
Bassler Bonnie LDirectorFeb 03Option Exercise380.951,021388,9502,268Feb 07 04:09 PM
Bassler Bonnie LDirectorFeb 03Sale779.001,021795,3591,247Feb 07 04:09 PM
Landry Robert EEVP Finance CFOFeb 03Sale764.50739564,96632,105Feb 07 04:09 PM
McCourt MarionEVP CommercialFeb 01Option Exercise372.461,100409,70623,179Feb 03 04:13 PM
McCourt MarionEVP CommercialFeb 01Sale752.191,100827,40922,079Feb 03 04:13 PM
RYAN ARTHUR FDirectorFeb 01Sale756.1310075,61319,247Feb 03 04:15 PM
BROWN MICHAEL SDirectorJan 27Option Exercise520.0115201,248Jan 30 04:11 PM
BROWN MICHAEL SDirectorJan 27Sale747.0017471,247Jan 30 04:11 PM
BROWN MICHAEL SDirectorJan 06Option Exercise520.013,0701,596,4314,317Jan 10 04:03 PM
BROWN MICHAEL SDirectorJan 06Sale747.143,0702,293,7201,247Jan 10 04:03 PM
McCourt MarionEVP CommercialJan 03Option Exercise372.461,100409,70623,179Jan 05 04:22 PM
McCourt MarionEVP CommercialJan 03Sale721.861,100794,04622,079Jan 05 04:22 PM
RYAN ARTHUR FDirectorJan 03Sale726.2910072,62919,182Jan 05 04:37 PM
COLES N ANTHONYDirectorDec 28Option Exercise442.245,7582,546,4106,851Dec 30 04:10 PM
COLES N ANTHONYDirectorDec 28Sale714.115,7584,111,8221,093Dec 30 04:10 PM
McCourt MarionEVP CommercialDec 12Sale730.17264192,76519,106Dec 13 04:13 PM